Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) Shares Outstanding (Weighted Average) (2022 - 2025)

Polomar Health Services has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $27.8 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) changed 0.45% year-over-year to $27.8 million; the TTM value through Sep 2025 reached $27.8 million, changed 0.45%, while the annual FY2024 figure was $27.7 million, 5.91% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $27.8 million at Polomar Health Services, up from $27.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $452.5 million in Q4 2022 and troughed at $292430.0 in Q3 2022.
  • A 4-year average of $65.5 million and a median of $27.7 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 34521.44% in 2023 and fell as far as 94.23% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $452.5 million in 2022, then tumbled by 94.23% to $26.1 million in 2023, then increased by 5.91% to $27.7 million in 2024, then increased by 0.45% to $27.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PMHS at $27.8 million in Q3 2025, $27.6 million in Q2 2025, and $27.7 million in Q1 2025.